Results 211 to 220 of about 1,759,457 (222)
Immune checkpoint inhibitors in HIV infection: current evidence on viral reservoir regulation and immune restoration. [PDF]
Front ImmunolWang Y +5 more
europepmc +1 more source
Shocking HIV-1 with immunomodulatory latency reversing agents [PDF]
Seminars in Immunology, 2021 The "shock-and-kill" strategy is one of the most explored HIV-1 cure approaches to eliminate latent virus. This strategy is based on HIV-1 reactivation using latency reversing agents (LRAs) to reactivate latent proviruses (the "shock" phase) and to ...
Gilles Darcis +2 more
exaly +2 more sources
The Current Status of Latency Reversing Agents for HIV-1 Remission
Annual Review of Virology, 2021 Combinatory antiretroviral therapy (cART) reduces human immunodeficiency virus type 1 (HIV-1) replication but is not curative because cART interruption almost invariably leads to a rapid rebound of viremia due to the persistence of stable HIV-1-infected ...
Gilles Darcis, Anthony Rodari
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Potential HIV latency-reversing agents with STAT1-activating activity from the leaves of
Phytochemistry, 2022Shi-Fei Li
exaly
Dendritic cells as natural latency reversing agent: A wake-up call for HIV-1
Virulence, 2017Dave Speijer
exaly
Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents
Expert Opinion on Drug DiscoveryShovanlal Gayen +2 more
exaly